The Salt Lake City-based L. S. Peery, M.D. Orthopaedic Innovation Center at the University of Utah’s Spencer Fox Eccles School of Medicine received FDA 510(k) clearance for the CoAptix S 7.5-millimeter system, a bone screw platform designed for fracture fixation and joint stabilization.
The system includes cannulated, headed and headless bone screws in lengths ranging from 45 to 180 millimeters and is engineered to provide continuous dynamic compression in the presence of up to 4 millimeters of resorption at the bone healing interface, according to an April 20 system news release.
The CoAptix S 7.5-millimeter system is part of the broader CoAptix platform, which includes bone screws, intramedullary fixation devices and hybrid devices aimed at fracture fixation, joint fusion and osteotomy stabilization.
Additional systems in smaller sizes, 3.5, 4.5, 5.5 and 6.5 millimeters, are in development, according to the release.
The platform is supported by six issued U.S. patents, with additional U.S. and international applications pending.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
